WegovyConcord, CA

Wegovy in Concord, CA

In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Wegovy® (Semaglutide, Injectable pen) by Novo Nordisk has been FDA-approved since 2021 for Chronic weight management. Weight Method offers a separate option for Concord residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.

FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Concord is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Wegovy in Concord, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in Concord from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Wegovy® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2021. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Concord, CA residents starts at $199/month.

What treatment options are available locally?

Concord is home to a large and vibrant Hispanic community, and Weight Method is committed to providing culturally competent care. Our bilingual providers understand the dietary traditions, family dynamics, and health concerns common in Hispanic households — and they deliver consultations in English or Spanish. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. Semaglutide does not require abandoning cultural foodways; it works by reducing appetite so you naturally eat smaller portions of the foods you love.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Semaglutide program starts at $199/month and covers your medication, provider consultations, and free delivery to Concord. No insurance claims, no prior authorizations, and no surprise bills. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Wegovy® is a Injectable pen manufactured by Novo Nordisk, FDA-approved since 2021 for Chronic weight management. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Wegovy® is taken Once weekly. Weight Method does not sell Wegovy®; we are a separate program that prescribes compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $199/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your Concord address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Weight Method's compounded Semaglutide program starts at $199/month in Concord. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Wegovy® is a separate FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; its retail price varies by pharmacy.

Start Your Treatment

Consult with a licensed provider in California and start Wegovy from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Concord

Nearby Cities

See More